Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination

PLoS Medicine

Volumn 10, Issue 6, 2013, Pages

  Sturrock, Hugh J W ^a   Hsiang, Michelle S ^a,b   Cohen, Justin M ^c   Smith, David L ^d   Greenhouse, Bryan ^b   Bousema, Teun ^e,f   Gosling, Roly D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CLINTON HEALTH ACCESS INITIATIVE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMAQUINE; TAFENOQUINE;

ARTICLE; ASYMPTOMATIC INFECTION; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; INDOOR RESIDUAL SPRAYING; INFECTION CONTROL; MALARIA; NONHUMAN; PARASITE PREVALENCE; PARASITE SERODIAGNOSIS; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SCREENING TEST;

ANTIMALARIALS; DISEASE ERADICATION; HEALTH PLAN IMPLEMENTATION; HUMANS; MALARIA; POPULATION SURVEILLANCE; RURAL POPULATION;

EID: 84879336744     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001467     Document Type: Article

References (74)

1. Gething PW, Smith DL, Patil AP, Tatem AJ, Snow RW, et al. (2010) Climate change and the global malaria recession. Nature 465: 342-345.
2. Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 379: 413-431.
3. Cotter C, Sturrock HJW, Hsiang MS, Liu J, Phillips AA, et al. (2013) The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet doi:10.1016/S0140-6736(13)60310-4.
4. Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, et al. (2012) Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med 9 (1): e1001165 doi:10.1371/journal.pmed.10011659.
5. Gething P, Patil A, Smith D, Guerra C, Elyazar I, et al. (2011) A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J 10: 378.
6. Bejon P, Williams TN, Liljander A, Noor AM, Wambua J, et al. (2010) Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. PLoS Med 7 (7): e1000304 doi:10.1371/journal.pmed.1000304.
7. Bousema T, Drakeley C, Gesase S, Hashim R, Magesa S, et al. (2010) Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis 201: 1764-1774.
8. Carter R, Mendis KN, Roberts D, (2000) Spatial targeting of interventions against malaria. Bull World Health Organ 78: 1401-1411.
9. Yangzom T, Gueye CS, Namgay R, Galappaththy GN, Thimasarn K, et al. (2012) Malaria control in Bhutan: case study of a country embarking on elimination. Malar J 11: 9.
10. Chuquiyauri R, Paredes M, Peñataro P, Torres S, Marin S, et al. (2012) Socio-demographics and the development of malaria elimination strategies in the low transmission setting. Acta Trop 121: 292-302.
11. Wesolowski A, Eagle N, Tatem AJ, Smith DL, Noor AM, et al. (2012) Quantifying the impact of human mobility on malaria. Science 338: 267-270.
12. WHO (2012) Disease surveillance for malaria elimination: an operational manual. Geneva: WHO. Available: http://www.who.int/malaria/publications/atoz/9789241503334/en/index.html. Accessed Feb 2013.
13. Bousema J, Gouagna L, Drakeley C, Meutstege A, Okech B, et al. (2004) Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J 3: 18.
14. Macauley C, (2005) Aggressive active case detection: a malaria control strategy based on the Brazilian model. Soc Sci Med 60: 563-573.
15. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LHP, et al. (2002) High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg 66: 641-648.
16. Pinto J, Sousa CA, Gil V, Ferreira C, Gonçalves L, et al. (2000) Malaria in São Tomé and Príncipe: parasite prevalences and vector densities. Acta Trop 76: 185-193.
17. Park CG, Chwae YJ, Kim JI, Lee JH, Hur GM, et al. (2000) Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax. Am J Trop Med Hyg 62: 720-725.
18. Laishram DD, Sutton PL, Nanda N, Sharma VL, Sobti RC, et al. (2012) The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malar J 11: 29.
19. Sanders K, Smith Gueye C, Phillips AA, Gosling R, (2012) Active case detection for malaria elimination: a confusion of acronyms and definitions. Malar Chemo Contr Elim 1.
20. The malERA Consultative Group on Monitoring Evaluation and Surveillance (2011) A research agenda for malaria eradication: monitoring, evaluation, and surveillance. PLoS Med 8 (1): e1000400 doi:10.1371/journal.pmed.1000400.
21. Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, et al. (2010) Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med 7 (8): e1000324 doi:10.1371/journal.pmed.1000324.
22. Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, et al. (2010) Operational strategies to achieve and maintain malaria elimination. Lancet 376: 1592-1603.
23. Stresman G, Kamanga A, Moono P, Hamapumbu H, Mharakurwa S, et al. (2010) A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia. Malar J 9: 265.
24. APMEN Country Partner Strategy and Intervention Matrices (2011). Asia Pacific Malaria Elimination Network. Available: http://apmen.org/country-resources/. Accessed Jan 2013.
25. Yekutiel P, (1960) Problems of epidemiology in malaria eradication. Bull World Health Organ 22: 669-683.
26. Zizhao L, Luoyuan S, Lian Z, Dongfang L, Yunpu S, (1999) Control strategies of malaria in Henan Province, China. Southeast Asian J Trop Med Public Health 30: 240-242.
27. Premanath M, (1997) Control of malaria: the rapid fever surveillance programme. J Assoc Physicians India 45: 853-856.
28. Lysenko A (1961) Organization of case detection in some malaria eradication programmes in the Americas. Available: https://extranetwhoint/iris/restricted/bitstream/10665/64820/1/WHO_Mal_301pdf. Accessed Feb 2013.
29. Ray A (1964) The discipline and dynamics of active case detection procedure under surveillance operations in a malaria eradication programme. Available: https://extranetwhoint/iris/restricted/bitstream/10665/65196/1/WHO_Mal_453pdf. Accessed Feb 2013.
30. Kern S, Tiono A, Makanga M, Gbadoe A, Premji Z, et al. (2011) Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis. Malar J 10: 210.
31. Sutcliffe CG, Kobayashi T, Hamapumbu H, Shields T, Mharakurwa S, et al. (2012) Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study. PLoS ONE 7 (2): e31396 doi:10.1371/journal.pone.0031396.
32. Tiono A, Ouedraogo A, Ogutu B, Diarra A, Coulibaly S, et al. (2013) A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso. Malar J 12: 79.
33. WHO (2012) Community-based reduction of malaria transmission. Available: http://whqlibdoc.who.int/publications/2012/9789241502719_eng.pdf. Accessed Feb 2013.
34. Tatarsky A, Aboobakar S, Cohen JM, Gopee N, Bheecarry A, et al. (2011) Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS ONE 6 (9): e23832 doi:10.1371/journal.pone.0023832.
35. Al-Zedjali MS, Director, Directorate of Malaria Eradication, Ministry of Health (2008) Malaria Elimination in Oman. Malaria Elimination Group Meeting. Brienz, Switzerland.
36. Kaneko A, Taleo G, Kalkoa M, Yamar S, Kobayakawa T, et al. (2000) Malaria eradication on islands. Lancet 356: 1560-1564.
37. Magnani R, Sabin K, Saidel T, Heckathorn D, (2005) Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 19: S67-S72.
38. Hay SI, Smith DL, Snow RW, (2008) Measuring malaria endemicity from intense to interrupted transmission. Lancet Infect Dis 8: 369-378.
39. Asih PB, Rozi IE, Herdiana H, Pratama NR, Hidayati AP, et al. (2012) The baseline distribution of malaria in the initial phase of elimination in Sabang Municipality, Aceh Province, Indonesia. Malar J 11: 291.
40. Jorgensen P, Nambanya S, Gopinath D, Hongvanthong B, Luangphengsouk K, et al. (2010) High heterogeneity in Plasmodium falciparum risk illustrates the need for detailed mapping to guide resource allocation: a new malaria risk map of the Lao People's Democratic Republic. Malar J 9: 59.
41. Yukich J, Taylor C, Eisele T, Reithinger R, Nauhassenay H, et al. (2013) Travel history and malaria infection risk in a low-transmission setting in Ethiopia: a case control study. Malar J 12: 33.
42. Dwyer DM, Strickler H, Goodman RA, Armenian HK, (1994) Use of case-control studies in outbreak investigations. Epidemiol Rev 16: 109-123.
43. Guthmann JP, Llanos-Cuentas A, Palacios A, Hall AJ, (2002) Environmental factors as determinants of malaria risk. A descriptive study on the northern coast of Peru. Trop Med Int Health 7: 518-525.
44. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, et al. (2006) Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis 193: 1151-1159.
45. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, et al. (2005) Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med 2 (4): e92 doi:10.1371/journal.pmed.0020092.
46. Seidahmed OME, Mohamedein MMN, Elsir AA, Ali FT, Malik EFM, et al. (2008) End-user errors in applying two malaria rapid diagnostic tests in a remote area of Sudan. Trop Med Int Health 13: 406-409.
47. Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, et al. (2013) Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial. J Infect Dis doi: 10.1093/infdis/jit077.
48. Clyde DF, (1962) Mass administration of an antimalarial drug combining 4-aminoquinoline and 8-aminoquinoline in Tanganyika. Bull World Health Organ 27: 203-212.
49. Coulibaly B, Zoungrana A, Mockenhaupt FP, Schirmer RH, Klose C, et al. (2009) Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial. PLoS ONE 4 (5): e5318 doi:10.1371/journal.pone.0005318.
50. WHO Evidence Review Group (2012) The safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide. Available: http://wwwwhoint/malaria/mpac/sep2012/primaquine_single_dose_pf_erg_meeting_report_aug2012pdf. Accessed Jan 2013.
51. Katz TM, Miller JH, Hebert AA, (2008) Insect repellents: historical perspectives and new developments. J Am Acad Dermatol 58: 865-871.
52. Kimani EW, Vulule JM, Kuria IW, Mugisha F, (2006) Use of insecticide-treated clothes for personal protection against malaria: a community trial. Malar J 5: 63.
53. Gosling RD, Ghani AC, Deen JL, von Seidlein L, Greenwood BM, et al. (2008) Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? Malar J 7: 54.
54. Sturrock HJW, Novotny JM, Kunene S, Dlamini S, Zulu Z, et al. (2013) Reactive case detection for malaria elimination: real-life experience from an ongoing programme in Swaziland. PLoS ONE 8: e63830 doi:10.1371/journal.pone.0063830.
55. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, et al. (2009) Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 9: 555-566.
56. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH, (2007) A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 77: 119-127.
57. Baltzell KA, Shakely D, Hsiang MS, Kemere J, Ali AS, et al. (2012) Prevalence of PCR detectable malaria infection among febrile patients with a negative Plasmodium falciparum specific rapid diagnostic test in Zanzibar. Am J Trop Med Hyg 88: 289-291.
58. WHO (2009) Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 2 (2009). Geneva: World Health Organization. Available: http://www.finddiagnostics.org/export/sites/default/resource-centre/reports_brochures/docs/rdt_malariaRd2_web.pdf Accessed Nov 2012.
59. Kim JY, Kim HH, Na BK, Kim YJ, Sohn Y, et al. (2012) Estimating the malaria transmission of Plasmodium vivax based on serodiagnosis. Malar J 11: 257.
60. Taylor WR, White NJ, (2004) Antimalarial drug toxicity: a review. Drug Saf 27: 25-61.
61. Kim S, Nguon C, Guillard B, Duong S, Chy S, et al. (2011) Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS ONE 6 (12): e28357 doi:10.1371/journal.pone.0028357.
62. Kinzer M, Chand K, Basri H, Lederman E, Susanti A, et al. (2010) Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu. Malar J 9: 89.
63. Okell LC, Ghani AC, Lyons E, Drakeley CJ, (2009) Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta analysis. J Infect Dis 200: 1509-1517.
64. Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, et al. (2012) Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 3: 1237.
65. Cordray MS, Richards-Kortum RR, (2012) Emerging Nucleic Acid-Based Tests for Point-of-Care Detection of Malaria. Am J Trop Med Hyg 87: 223-230.
66. Ishengoma DS, Lwitiho S, Madebe RA, Nyagonde N, Persson O, et al. (2011) Using rapid diagnostic tests as source of malaria parasite DNA for molecular analyses in the era of declining malaria prevalence. Malar J 10: 6.
67. Congpuong K, SaeJeng A, Sug-aram R, Aruncharus S, Darakapong A, et al. (2012) Mass blood survey for malaria: pooling and realtime PCR combined with expert microscopy in north-west Thailand. Malar J 11: 288.
68. Corran P, Coleman P, Riley E, Drakeley C, (2007) Serology: a robust indicator of malaria transmission intensity? Trends Parasitol 23: 575-582.
69. Alonso PL, Barnwell JW, Bell D, Hanson K, Mendis K, et al. (2011) A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med 8 (1): e1000396 doi:10.1371/journal.pmed.1000396.
70. Bousema T, Youssef RM, Cook J, Cox J, Alegana VA, et al. (2010) Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis 16: 392-399.
71. Shanks GD, (2012) Control and Elimination of Plasmodium vivax. Adv Parasitol 80: 301-341.
72. von Seidlein L, Greenwood BM, (2003) Mass administrations of antimalarial drugs. Trends Parasitol 19: 452-460.
73. Enk MJ, Lima ACL, Massara CL, Coelho PMZ, Schall VT, (2008) A combined strategy to improve the control of Schistosoma mansoni in areas of low prevalence in Brazil. Am J Trop Med Hyg 78: 140-146.
74. Massara CL, Peixoto SV, Enk MJ, da Silva Barros H, dos Santos Carvalho O, et al. (2006) Evaluation of an improved approach using residences of schistosomiasis-positive school children to identify carriers in an area of low endemicity. Am J Trop Med Hyg 74: 495-499.